Related references
Note: Only part of the references are listed.EPA guidance on assessment of negative symptoms in schizophrenia
S. Galderisi et al.
EUROPEAN PSYCHIATRY (2021)
Standard measurement error and minimal detectable change of the Back-PAQ ArgSpan questionnaire: Secondary analysis
Federico Jose Villalba et al.
MUSCULOSKELETAL SCIENCE AND PRACTICE (2021)
The brief negative symptom scale in translation: A review of psychometric properties and beyond
Kazunori Tatsumi et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2020)
Factorial Structure of the Serbian Version of the Clinical Assessment Interview for Negative Symptoms - Evidence for Three Factors of Negative Symptoms
Ivan Ristic et al.
FRONTIERS IN PSYCHOLOGY (2020)
A large European, multicenter, multinational validation study of the Brief Negative Symptom Scale
Armida Mucci et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2019)
Cross Cultural Validation and Extension of the Clinical Assessment Interview for Negative Symptoms (CAINS) in the Chinese Context: Evidence from a Spectrum Perspective
Dong-jie Xie et al.
SCHIZOPHRENIA BULLETIN (2018)
Validation of the Korean-Version of the Clinical Assessment Interview for Negative Symptoms of Schizophrenia (CAINS)
Sung Il Jung et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2016)
A Psychometric Comparison of the Clinical Assessment Interview for Negative Symptoms and the Brief Negative Symptom Scale
Gregory P. Strauss et al.
SCHIZOPHRENIA BULLETIN (2016)
Validation of the Spanish version of the Clinical Assessment for Negative Symptoms (CAINS)
Alicia Valiente-Gomez et al.
SCHIZOPHRENIA RESEARCH (2015)
Validation of the German version of the Clinical Assessment Interview for Negative Symptoms (CAINS)
Maike Engel et al.
PSYCHIATRY RESEARCH (2014)
The Clinical Assessment Interview for Negative Symptoms (CAINS): Final Development and Validation
Ann M. Kring et al.
AMERICAN JOURNAL OF PSYCHIATRY (2013)
The Brief Negative Symptom Scale: Psychometric Properties
Brian Kirkpatrick et al.
SCHIZOPHRENIA BULLETIN (2011)
Toward the Next Generation of Negative Symptom Assessments: The Collaboration to Advance Negative Symptom Assessment in Schizophrenia
Jack J. Blanchard et al.
SCHIZOPHRENIA BULLETIN (2011)
Development and psychometric validation of the Clinical Assessment Interview for Negative Symptoms (CAINS)
William P. Horan et al.
SCHIZOPHRENIA RESEARCH (2011)
Periods of Recovery in Deficit Syndrome Schizophrenia: A 20-Year Multi-follow-up Longitudinal Study
Gregory P. Strauss et al.
SCHIZOPHRENIA BULLETIN (2010)
Initial development and preliminary validation of a new negative symptom measure The Clinical Assessment Interview for Negative Symptoms (CAINS)
Courtney Forbes et al.
SCHIZOPHRENIA RESEARCH (2010)
How effective are second-generation antipsychotic drugs? A meta-analysis of placebo-controlled trials
S. Leucht et al.
MOLECULAR PSYCHIATRY (2009)
Pharmacological treatment of primary negative symptoms in schizophrenia: A systematic review
Brendan P. Murphy et al.
SCHIZOPHRENIA RESEARCH (2006)
A brief guide to structural equation modeling
Rebecca Weston et al.
COUNSELING PSYCHOLOGIST (2006)
The structure of negative symptoms within schizophrenia: Implications for assessment
JJ Blanchard et al.
SCHIZOPHRENIA BULLETIN (2006)
The NIMH-MATRICS consensus statement on negative symptoms
B Kirkpatrick et al.
SCHIZOPHRENIA BULLETIN (2006)
Principles of good practice for the translation and cultural adaptation process for patient-reported outcomes (PRO) measures: Report of the ISPOR Task Force for Translation and Cultural Adaptation
D Wild et al.
VALUE IN HEALTH (2005)
The relationship of symptoms and level of functioning in schizophrenia to general wellbeing and the Quality of Life Scale
RMG Norman et al.
ACTA PSYCHIATRICA SCANDINAVICA (2000)
Schizophrenia and quality of life
H Katschnig
ACTA PSYCHIATRICA SCANDINAVICA (2000)
Share Paper
